0001062993-24-005772.txt : 20240306 0001062993-24-005772.hdr.sgml : 20240306 20240306194502 ACCESSION NUMBER: 0001062993-24-005772 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240304 FILED AS OF DATE: 20240306 DATE AS OF CHANGE: 20240306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HERSHBERG ROBERT CENTRAL INDEX KEY: 0001274139 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 24727778 MAIL ADDRESS: STREET 1: 3005 FIRST AVENUE CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-03-04 0001478320 Adaptive Biotechnologies Corp ADPT 0001274139 HERSHBERG ROBERT C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST SEATTLE WA 98109 1 0 0 0 0 Common Stock 2024-03-04 4 A 0 31328 0 A 107296 D Stock Option (right to buy) 3.99 2024-03-04 4 A 0 48044 0 A 2034-03-04 Common Stock 48044 48044 D The option will vest in equal monthly installments over one year from March 4, 2024, subject to continued service as a director through such vesting dates. /s/ Robert Hershberg by Stacy L Taylor, Attorney-in-Fact 2024-03-06